Skip to main content

Merck & Co., Inc. balance sheet

  • MRK · NYSE
  • Pharmaceuticals
  • S&P 500
$147.76+0.55%Close 13 Nov 2026 · Market value $361.6B

At the end of fiscal 2025 (the year to 31 Dec 2025), Merck & Co., Inc. reported total assets of $136.9B, $14.56B in cash and equivalents, $50.49B of total debt; shareholders' equity was $52.61B.

From Merck & Co., Inc.'s annual and quarterly reports, each period checked against accounting identities; a figure that does not pass is left blank. Fiscal years follow the company's calendar, the latest ending 31 Dec 2025.

Annual

Merck & Co., Inc. balance sheet, annual
USDFY 2007FY 2008FY 2009FY 2010FY 2011FY 2012FY 2013FY 2014FY 2015FY 2016FY 2017FY 2018FY 2019FY 2020FY 2021FY 2022FY 2023FY 2024FY 2025
Cash and equivalents$5.34B$4.37B$9.31B$10.90B$13.53B$13.45B$15.62B$7.44B$8.52B$6.51B$6.09B$7.96B$9.68B$8.05B$8.10B$12.69B$6.84B$13.24B$14.56B
Short-term investments—$1.12B$293.0M$1.30B$1.44B$2.69B$1.86B$8.28B$4.90B$7.83B$2.41B$899.0M$774.0M$0.00$0.00$498.0M$252.0M$447.0M$0.00
Cash and short-term investments$5.34B$5.49B$9.60B$12.20B$14.97B$16.14B$17.49B$15.72B$13.43B$14.34B$8.50B$8.86B$10.45B$8.05B$8.10B$13.19B$7.09B$13.69B$14.56B
Accounts receivable—$2.82B—$7.34B$8.26B$7.67B$7.18B$6.63B$6.48B$7.02B$6.87B$7.07B$6.78B$6.80B$9.23B$9.45B$10.35B$10.28B$11.78B
Inventory—$2.09B$8.05B$5.87B$6.25B$6.54B$6.23B$5.57B$4.70B$4.87B$5.10B$5.44B$5.98B$5.55B$5.95B$5.91B$6.36B$6.11B$6.66B
Current assets—$19.11B$28.43B$29.06B$33.18B$34.86B$35.69B$32.60B$29.75B$30.61B$24.77B$25.88B$27.48B$27.76B$30.27B$35.72B$32.17B$38.78B$43.52B
Property, plant and equipment—$12.00B$18.28B$17.08B$16.30B$16.03B$14.97B$13.14B$12.51B$12.03B$12.44B$13.29B$15.05B$17.00B$19.28B$21.42B$23.05B$23.78B$25.32B
Goodwill—$1.44B$12.04B$12.38B$12.15B$12.13B$12.30B$12.99B$17.72B$18.16B$18.28B$18.25B$19.43B$18.88B$21.26B$21.20B$21.20B$21.67B$21.58B
Acquired intangibles—$525.4M$47.76B$39.46B$34.30B$29.08B$23.80B$20.39B$22.60B$17.30B$14.18B$13.10B$14.20B$14.10B$22.93B$20.27B$18.01B$16.37B$26.68B
Long-term investments—$6.49B$432.0M$2.17B$3.46B$7.30B$9.77B$13.52B$13.04B$11.42B$12.13B$6.23B$1.47B$785.0M$370.0M$1.01B$252.0M$463.0M$956.0M
Total assets—$47.20B$112.3B$105.8B$105.1B$106.1B$105.6B$98.17B$101.7B$95.38B$87.87B$82.64B$84.40B$91.59B$105.7B$109.2B$106.7B$117.1B$136.9B
Accounts payable—$617.6M$2.24B$2.31B$2.02B$1.75B$2.27B$2.63B$2.53B$2.81B$3.10B$3.32B$3.74B$4.33B$4.61B$4.26B$3.92B$4.08B$4.40B
Long-term debt · current portion—$2.30B$1.38B$2.40B$1.99B$1.80B$2.10B$1.00B$2.30B$300.0M$3.00B$5.31B$1.90B$2.30B$2.30B$1.70B$1.30B$2.50B$2.30B
Current liabilities—$14.32B$15.64B$15.64B$16.25B$18.35B$17.87B$18.40B$19.20B$17.20B$18.61B$22.21B$22.22B$27.33B$23.87B$24.24B$25.69B$28.42B$28.33B
Long-term debt · non-current—$3.94B$16.09B$15.48B$15.53B$16.25B$20.54B$18.70B$23.83B$24.27B$21.35B$19.81B$22.74B$25.36B$30.69B$28.75B$33.68B$34.46B$46.75B
Operating lease liability————————————$1.00B$1.63B$1.53B$1.29B$1.21B$1.16B$1.20B
Total liabilities—$26.03B$50.83B$48.98B$48.19B$50.67B$53.32B$49.38B$56.91B$55.07B$53.30B$55.76B$58.40B$66.18B$67.44B$63.10B$69.04B$70.73B$84.20B
Retained earnings—$43.70B$41.41B$37.54B$38.99B$39.98B$39.26B$46.02B$45.35B$44.13B$41.35B$42.58B$46.60B$47.36B$53.70B$61.08B$53.90B$63.07B$73.08B
Minority interest—$2.41B$2.43B$2.43B$2.43B$2.44B$2.56B$144.0M$91.00M$220.0M$233.0M$181.0M$94.00M$87.00M$73.00M$67.00M$54.00M$59.00M$56.00M
Shareholders' equity$20.59B$18.76B$59.06B$54.38B$54.52B$53.02B$49.77B$48.65B$44.68B$40.09B$34.34B$26.70B$25.91B$25.32B$38.18B$45.99B$37.58B$46.31B$52.61B
Total liabilities and equity—$47.20B$112.3B$105.8B$105.1B$106.1B$105.6B$98.17B$101.7B$95.38B$87.87B$82.64B$84.40B$91.59B$105.7B$109.2B$106.7B$117.1B$136.9B
Total debt—$6.24B$17.47B$17.88B$17.52B$18.05B$22.64B$19.70B$26.13B$24.57B$24.35B$25.10B$27.30B$33.43B$34.63B$31.99B$36.31B$38.26B$50.49B
Net debt—$754.0M$7.87B$5.68B$2.54B$1.91B$5.15B$3.98B$12.70B$10.23B$15.86B$16.24B$16.85B$25.38B$26.53B$18.80B$29.22B$24.57B$35.93B
Net working capital—$425.6M$3.48B$2.52B$3.40B$3.06B$2.20B$6.77B$2.03B$6.89B$60.00M−$4.30B−$4.41B−$7.61B−$1.70B−$1.21B−$367.0M−$2.88B$624.0M
Shares outstanding · period end——3.1B3.1B3.0B3.0B2.9B2.8B2.8B2.7B2.7B2.6B2.5B2.5B2.5B2.5B2.5B2.5B2.5B

Quarterly

Merck & Co., Inc. balance sheet, quarterly
USDQ4 FY2023Q1 FY2024Q2 FY2024Q3 FY2024Q4 FY2024Q1 FY2025Q2 FY2025Q3 FY2025Q4 FY2025Q1 FY2026Q2 FY2026Q3 FY2026
Cash and equivalents$6.84B$5.58B$11.30B$14.59B$13.24B$8.63B$8.01B$18.17B$14.56B$5.33B$6.85B$9.55B
Short-term investments$252.0M$40.00M$50.00M$0.00$447.0M$599.0M$615.0M$45.00M$0.00$375.0M$292.0M$100.0M
Cash and short-term investments$7.09B$5.62B$11.35B$14.59B$13.69B$9.23B$8.62B$18.21B$14.56B$5.70B$7.14B$9.65B
Accounts receivable$10.35B$11.37B$11.64B$11.38B$10.28B$10.79B$11.85B$12.12B$11.78B$12.21B$12.56B$12.74B
Inventory$6.36B$6.51B$6.47B$6.24B$6.11B$6.20B$6.60B$6.44B$6.66B$6.48B$6.21B$6.16B
Current assets$32.17B$31.45B$38.20B$40.36B$38.78B$35.50B$37.06B$47.56B$43.52B$35.02B$36.68B$38.94B
Property, plant and equipment$23.05B$23.05B$23.22B$23.45B$23.78B$24.79B$25.24B$25.64B$25.32B$25.43B$25.74B$25.90B
Goodwill$21.20B$21.18B$21.16B$21.70B$21.67B$21.68B$21.59B$21.59B$21.58B$21.58B$21.58B$21.95B
Acquired intangibles$18.01B$17.57B$16.98B$17.01B$16.37B$15.76B$15.19B$15.31B$26.68B$25.75B$24.98B$24.48B
Long-term investments$252.0M$280.0M$357.0M$575.0M$463.0M$616.0M$774.0M$1.12B$956.0M$1.10B$1.22B$1.60B
Total assets$106.7B$105.8B$112.6B$117.5B$117.1B$115.1B$117.5B$129.5B$136.9B$128.7B$129.8B$132.8B
Accounts payable$3.92B$3.51B$3.52B$3.59B$4.08B$3.78B$3.89B$4.15B$4.40B$3.86B$3.83B$5.03B
Long-term debt · current portion$1.30B$3.08B$3.07B$3.15B$2.50B$1.36B$1.43B$1.41B$2.30B$2.44B$2.83B$4.09B
Current liabilities$25.69B$25.10B$26.06B$29.59B$28.42B$25.17B$26.04B$28.63B$28.33B$26.95B$27.73B$28.80B
Long-term debt · non-current$33.68B$31.14B$34.72B$34.98B$34.46B$33.48B$33.97B$39.97B$46.75B$46.67B$51.08B$49.69B
Operating lease liability$1.21B———$1.16B———$1.20B———
Total liabilities$69.04B$65.42B$68.98B$72.97B$70.73B$66.72B$68.46B$77.64B$84.20B$82.75B$87.82B$87.83B
Retained earnings$53.90B$56.70B$60.19B$61.38B$63.07B$66.10B$68.48B$72.23B$73.08B$66.72B$63.27B$66.22B
Minority interest$54.00M$60.00M$66.00M$58.00M$59.00M$65.00M$67.00M$57.00M$56.00M$53.00M$51.00M$53.00M
Shareholders' equity$37.58B$40.36B$43.58B$44.50B$46.31B$48.34B$48.99B$51.85B$52.61B$45.88B$41.93B$44.89B
Total liabilities and equity$106.7B$105.8B$112.6B$117.5B$117.1B$115.1B$117.5B$129.5B$136.9B$128.7B$129.8B$132.8B
Total debt$36.31B$34.20B$37.80B$38.10B$38.26B$34.80B$35.40B$41.40B$50.49B$49.10B$53.90B$53.80B
Net debt$29.22B$28.58B$26.45B$23.51B$24.57B$25.57B$26.78B$23.19B$35.93B$43.40B$46.76B$44.15B
Net working capital−$367.0M$767.0M$841.0M−$3.82B−$2.88B$1.70B$3.02B$760.0M$624.0M$2.74B$2.10B$590.0M
Shares outstanding · period end2.5B2.5B2.5B2.5B2.5B2.5B2.5B2.5B2.5B2.5B2.5B2.5B

The main figures as JSON and plain text. See data and methodology.

MRK in the terminal

Every line back twenty years, charts of any figure, segments and KPIs by quarter, valuation and alerts.